Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Robert Knight who wrote (683)	7/1/1998 12:20:00 AM
From: jake burns	Read Replies (1) \| Respond to of 1510

Robert, after viewing the trading the past 3 days, is it your belief that cibc oppenheimer has yet to begin to buy back ANY of the shares they are short? In other words, are they still not convinced that IMNR is for real? Seems to me a more prudent strategy, given the downside risk, would be to buy back as many shares as possible in the 15 dollar range while they still have the chance...but they haven't done so, right?

To: Robert Knight who wrote (683)	7/1/1998 8:04:00 AM
From: AHM	Read Replies (3) \| Respond to of 1510

I disagree - market makers cannot depress a bid level artificially if buyers want the stock more than owners are willing to release their shares at depressed prices. If market makers are building inventory or covering shorts at depressed prices they cannot do so unless sellers are willing to release shares at the same market levels. There are no hobgoblins here - those who are selling do not anticipate the rise in value to occur in the next few trading days that many others expect. Instead of complaining about it, take advantage of these low prices and buy more while you still can!!